APA (7th ed.) Citation

LC, D., L, B., D, G., G, G., M, G., J, K., . . . D, F. (2025). Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases. Cytotherapy, 27(11), 1326. https://doi.org/10.1016/j.jcyt.2025.06.005

Chicago Style (17th ed.) Citation

LC, Davies, et al. "Defining Minimal Criteria for Peer-reviewed Reporting of Mesenchymal Stromal Cell Clinical Trials for Autoimmune Diseases." Cytotherapy 27, no. 11 (2025): 1326. https://doi.org/10.1016/j.jcyt.2025.06.005.

MLA (9th ed.) Citation

LC, Davies, et al. "Defining Minimal Criteria for Peer-reviewed Reporting of Mesenchymal Stromal Cell Clinical Trials for Autoimmune Diseases." Cytotherapy, vol. 27, no. 11, 2025, p. 1326, https://doi.org/10.1016/j.jcyt.2025.06.005.